Inventiva
IVA | XPAR
Overview
Corporate Details
- ISIN(s):
- FR0013233012 (+2 more)
- LEI:
- 969500I9Y690B3FZW590
- Country:
- France
- Address:
- 50 RUE DE DIJON, 21121 DAIX
- Website:
- https://inventivapharma.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
We are a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology. We have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. By leveraging these assets and expertise, we are advancing two clinical candidates in two indications, as well as a deep pipeline of earlier stage programs.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-23 08:30 |
Earnings Release
Inventiva reports 2025 First Quarter Financial Information¹
|
English | 299.4 KB | |
| 2025-05-23 08:30 |
Earnings Release
Inventiva publie ses informations financières¹ du 1er trimestre 2025
|
French | 335.4 KB | |
| 2025-05-23 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2…
|
English | 348.3 KB | |
| 2025-05-23 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunies le 2…
|
French | 347.8 KB | |
| 2025-05-22 14:00 |
Transaction in Own Shares
Descriptif du Programme de Rachat d’Actions Pouvant Être Mis en Œuvre dans le C…
|
French | 275.8 KB | |
| 2025-05-22 14:00 |
Transaction in Own Shares
Description of the Share Repurchase Program Covered by the Liquidity Agreement …
|
English | 256.1 KB | |
| 2025-05-16 14:43 |
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuil
|
French | 110.4 KB | |
| 2025-05-15 14:26 |
Regulatory News Service
Franchissements de seuils
|
French | 128.0 KB | |
| 2025-05-15 14:25 |
Regulatory News Service
Franchissement de seuil et déclaration d'intention
|
French | 116.0 KB | |
| 2025-05-13 11:24 |
Major Shareholding Notification
Franchissement de seuils
|
French | 111.5 KB | |
| 2025-05-13 11:14 |
Major Shareholding Notification
Franchissement de seuil
|
French | 111.7 KB | |
| 2025-05-05 08:30 |
Capital/Financing Update
Inventiva obtient la deuxième tranche de 116 millions d'euros de son financemen…
|
French | 699.3 KB | |
| 2025-05-05 08:30 |
Capital/Financing Update
Inventiva secures the €116 million second tranche of its structured financing o…
|
English | 518.0 KB | |
| 2025-04-30 22:00 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d’actions composant l…
|
French | 261.1 KB | |
| 2025-04-30 22:00 |
Declaration of Voting Results & Voting Rights Announcements
Statement of total voting rights and shares forming the company’s share capital…
|
English | 236.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-05 | N/A | Other | Buy | 10,000 | N/A |
| 2023-12-08 | N/A | Other | Buy | 15,000 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |